According to our latest report entitled “US Stem Cell Market Analysis”, the stem cell market in the US has been growing at a fast pace for the past few years. The country is one of the major stem cell markets in the world and is witnessing a large number of transplantations and significant developments in cord blood banking market. The US stem cell market reached to the mark of US$ 830 Million in 2010 and backed by factors, such as the government support and huge investments, the market is likely to grow at an impressive CAGR of 70% during 2011-2013 to reach US$ 4 Billion by 2013 end.
Our report has found that a regenerative medicine sector is making considerable contribution to the overall US stem cell market. This particular segment offers immense opportunities in the areas of orthopedics, vascular, cardiac treatment, and reconstructive surgery. The regenerative medicine market in the US was around US$ 176 Million in 2010 and is further likely to grow at a splendid rate in near future.
The report “US Stem Cell Market Analysis” covers all the key aspects of the US stem cell market and broadly outlines all the important trends and factors that have had a huge impact on the industry’s performance. The report divides the market by technology and products and further classifies them in sub-segments. Stem cell market developments and trends in key states have also been provided.
The report provides extensive research and thorough analysis of the current industry trends and factors, which are driving the growth of stem cell market in the US. This report highlights the emerging segments in the market along with their potential to serve the country’s population. The future projection makes use of reliable methods and techniques, which facilitate presentation of the real outlook. Overall, the report is likely to help clients better understand the US stem cell market structure and future developments.
For more information visit: http://www.rncos.com/Report/IM191.htm |
